| Abstrakt: |
Keywords for this news article include: Universidad Nacional de Quilmes, Angiogenic Proteins, Antineoplastic Monoclonal Antibodies, Antineoplastics, Bevacizumab Therapy, Biosimilars, Cancer, Carcinomas, Drugs and Therapies, Growth Factor Receptors, Health and Medicine, Immunologic Agents, Intercellular Signaling Peptides and Proteins, Membrane Proteins, Monoclonal Antibodies, Oncology, Pharmaceuticals, Phosphotransferases, Protein Kinases, Receptor Protein-Tyrosine Kinases, Tyrosine Kinase Inhibitors, VEGF, VEGF - VEGFR Inhibitors, VEGFR Inhibitors, Vascular Endothelial Growth Factors. Keywords: Angiogenic Proteins; Antineoplastic Monoclonal Antibodies; Antineoplastics; Bevacizumab Therapy; Biosimilars; Cancer; Carcinomas; Drugs and Therapies; Growth Factor Receptors; Health and Medicine; Immunologic Agents; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Monoclonal Antibodies; Oncology; Pharmaceuticals; Phosphotransferases; Protein Kinases; Receptor Protein-Tyrosine Kinases; Tyrosine Kinase Inhibitors; VEGF; VEGF - VEGFR Inhibitors; VEGFR Inhibitors; Vascular Endothelial Growth Factors EN Angiogenic Proteins Antineoplastic Monoclonal Antibodies Antineoplastics Bevacizumab Therapy Biosimilars Cancer Carcinomas Drugs and Therapies Growth Factor Receptors Health and Medicine Immunologic Agents Intercellular Signaling Peptides and Proteins Membrane Proteins Monoclonal Antibodies Oncology Pharmaceuticals Phosphotransferases Protein Kinases Receptor Protein-Tyrosine Kinases Tyrosine Kinase Inhibitors VEGF VEGF - VEGFR Inhibitors VEGFR Inhibitors Vascular Endothelial Growth Factors 1263 1263 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on carcinomas. [Extracted from the article] |
